SCHEMBL742320

SCHEMBL742320

COc1ccccc1C(=O)Nc1n[nH]c2sc(C(=O)NC(C)(C)c3ccccc3)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.44
ABL1 P00519 2/20 0.42
BCR P11274 2/20 0.42
CDC7 O00311 1/20 0.42
MAP4K4 O95819 1/20 0.42
PIM1 P11309 1/20 0.42
CDK2 P24941 1/20 0.42
GSK3B P49841 1/20 0.42
HIPK2 Q9H2X6 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
NPC1 O15118 4/20 0.41
RAB9A P51151 2/20 0.41
RXFP1 Q9HBX9 2/20 0.41
ROCK2 O75116 1/20 0.40
ROCK1 Q13464 1/20 0.40
NCS1 P62166 1/20 0.40
KCNK3 O14649 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1780888 0.96 RXFP1 (0.46) AURKAABL1BCRCDC7MAP4K4
SCHEMBL2416143 0.91 NPC1 (0.43) CDC7MAP4K4PIM1CDK2GSK3B
SCHEMBL741093 0.87 AURKA (0.46) AURKAABL1BCRMAP4K4PIM1
SCHEMBL4632642 0.86 ADORA3 (0.48) CDC7MAP4K4PIM1CDK2GSK3B
SCHEMBL1780795 0.86 AURKA (0.45) AURKAABL1BCRRXFP1
SCHEMBL2411496 0.85 KCNK3 (0.52) CDC7MAP4K4PIM1CDK2GSK3B
SCHEMBL1779927 0.85 RXFP1 (0.49) AURKAABL1BCRNPC1RAB9A
SCHEMBL740292 0.85 AURKA (0.55) AURKAABL1BCRCDK2NPC1
SCHEMBL741609 0.85 AURKA (0.52) AURKAABL1BCRCDK2ADORA3
SCHEMBL1779700 0.85 AURKA (0.50) AURKAABL1BCRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed